ISCIII will represent Spain in the largest research appointment in Europe

Source: redaccionmedica.com The director of the Health Institute Carlos III (ISCIII), Raquel Yotti Álvarez, in charge of the head of the Spanish delegation at the opening ceremony of the ‘EU-Openscreen ERIC’, which will take place in Berlin (Germany) next Tuesday, the 25th of September. Spain is one of the seven founding members of this new […]

EMA gives a positive opinion to Gilenya, from Novartis, for minors with multiple sclerosis

Source: actasanitaria.com The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of the drug Gilenya (fingolimod), from the pharmaceutical company Novartis, to treat children and adolescents from 10 to 17 years of age with referral forms recurrent multiple sclerosis. If approved, said pharmaceutical company indicates […]

Nobel Prize for Medicine 2018 for cancer immunotherapy

Source: IntraMed The American James Allison and the Japanese Tasuku Honjo have won the Nobel Prize for Medicine 2018. The jury of the Karolinska Institute in Stockholm has awarded the prize to these two scientists for “their discovery of cancer therapy by inhibiting negative immune regulation ” The findings of both scientists have been essential […]

VHIO develops a precision immunotherapy for breast cancer

Source: redaccionmedica.com Researchers at the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona have achieved that immunotherapy attacks only the tumor cells of a type of breast cancer in patients who do not respond to other treatments, an action “at home” that solves one of The main challenges for this novel strategy in Oncology. The […]

Genetic mutations also alter the nature of clinical trials

Source: immedicohospitalario.es New ways of researching and developing drugs, in their most advanced oncological aspects, urge health administrations, hospitals, patients and their organizations, Research Ethics Committees (CEIm), Contract Research Organizations (CRO) and national and transnational companies arbitrate systems that make available the most innovative therapies available to patients. Currently, the research for the development and […]

Europe approves Verzenios, from Lilly, for the treatment of advanced breast cancer

Source: actasanitaria.com The European Commission has authorized the commercialization of Verzenios (abemaciclib), from the pharmaceutical company Lilly, as a treatment of locally advanced or metastatic breast cancer with positive hormone receptors (HR +) and receptor 2 of human negative epidermal growth factor (HER2-) , in combination with an aromatase inhibitor (AI) or fulvestrant as a […]

Clinical Trials Area of the Hospital Pharmacy Service

Distefar, considera que las funciones que se llevan a cabo en el servicio de farmacia hospitalaria, dentro del entorno de un estudio con medicamentos, son fundamentales para el buen funcionamiento de un ensayo clínico. El área de ensayos clínicos del servicio de farmacia, está interrelacionado con el personal de los distintos servicios que realizan ensayos […]

AstraZeneca Foundation encourages young talent with 80,000 euros

Source: redaccionmedica.com The AstraZeneca Foundation, in collaboration with the Carlos III Health Institute, has announced the winners of the IV Young Researchers Awards, a recognition that drives the scientific career of researchers under 40 years of age. In this fourth edition, the winners are Gabriel Sanfélix-Gimeno in the category of Acute Coronary Syndrome, Guadalupe Sabio […]

International cooperation in the pharmaceutical industry: key to innovation and global access

Partnerships between companies and regulatory authorities are becoming an essential strategy for tackling global challenges. Partnerships between companies and regulatory authorities are becoming an essential strategy for tackling global challenges. Consalud.es In a context marked by globalisation, the pharmaceutical industry is evolving towards an increasingly international dimension, where cooperation between companies, academic institutions and governments […]

Ayuso announces a 34% increase in investment in scientific research, reaching €752 million

The Community of Madrid aims to strengthen research excellence, attract talent, and consolidate the region as a national and international benchmark in this field. consalud.es The Community of Madrid will increase investment in scientific research by 34% with the aim of strengthening research excellence, attracting talent, and consolidating the region as a national and international […]